Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38292
CAS Number:
70024-40-7
Terazosin hydrochloride dihydrate
Purity:
≥ 98% (HPLC)
Synonym(s):
4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazolinehydrochloride dihydrate
Documents
$20.63 /100MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Terazosin hydrochloride dihydrate is a potent alpha-1 adrenergic antagonist primarily utilized in the treatment of hypertension and benign prostatic hyperplasia (BPH). This compound works by relaxing blood vessels and improving urine flow, making it a valuable option for patients experiencing urinary difficulties associated with prostate enlargement. Its unique structure, featuring a piperazine ring and a quinazoline moiety, enhances its efficacy and selectivity, providing a favorable safety profile compared to other antihypertensive agents.

In addition to its therapeutic applications, Terazosin hydrochloride dihydrate is also of interest in research settings, particularly in studies related to cardiovascular health and urology. Its ability to modulate smooth muscle tone has led to investigations into its potential benefits in various conditions, including heart failure and peripheral vascular disease. Researchers and healthcare professionals appreciate its versatility and effectiveness, making it a reliable choice in both clinical and experimental environments.

Synonyms
4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazolinehydrochloride dihydrate
CAS Number
70024-40-7
Purity
≥ 98% (HPLC)
Molecular Formula
C19H25N5O4·HCl·2H2O
Molecular Weight
459.93
MDL Number
MFCD00941408
PubChem ID
63016
Melting Point
273 - 275 °C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
4-Amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazolinehydrochloride dihydrate
CAS Number
70024-40-7
Purity
≥ 98% (HPLC)
Molecular Formula
C19H25N5O4·HCl·2H2O
Molecular Weight
459.93
MDL Number
MFCD00941408
PubChem ID
63016
Melting Point
273 - 275 °C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Terazosin hydrochloride dihydrate is widely utilized in research focused on

  • Hypertension Management: This compound is primarily used in the treatment of high blood pressure, helping to relax blood vessels and improve blood flow, making it a vital medication in cardiology.
  • BPH Treatment: It is effective in alleviating symptoms of benign prostatic hyperplasia (BPH), providing relief from urinary difficulties in men, which is crucial for urologists and primary care providers.
  • Research in Pharmacology: Terazosin serves as a model compound in pharmacological studies, allowing researchers to explore alpha-1 adrenergic receptor antagonism, which is essential for developing new medications.
  • Veterinary Medicine: The compound is also investigated for potential applications in veterinary medicine, particularly for treating conditions related to hypertension in animals.
  • Combination Therapies: Its use in combination with other antihypertensive agents is being explored, offering enhanced therapeutic effects and improved patient outcomes in clinical settings.

Citations